Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
Department of Obstetrics and Gynecology, Osaka General Medical Center, 3-1-56, Bandaihigashi, Sumiyoshiku, Osaka, Osaka, 558-8558, Japan.
Int J Clin Oncol. 2022 Aug;27(8):1356-1363. doi: 10.1007/s10147-022-02173-1. Epub 2022 May 7.
In Japan, the government suspended HPV vaccine recommendation in 2013, resulting in dropping vaccination uptake to almost zero. We conducted four serial surveys on our colleague' attitude to HPV vaccination between 2014 and 2021. Here, we evaluate the result of the survey in 2021 and compare it to previous surveys.
The subjects were 567 obstetricians and gynecologists who had been trained in our university hospital or our affiliated hospitals. We used a questionnaire similar in format to those used in 2014, 2017, and 2019.
A total of 340 doctors (60.0%) completed the survey. Among them, 93.2% (317/340) of respondents thought that the government should restart HPV vaccination recommendation, and that 63.2% (215/340) think male teenagers should also vaccinate against HPV. The percentage of teenaged daughters inoculated with HPV vaccination after Japanese government had suspended its recommendation was 43.5% (20/46), an increasing trend from the previous surveys. 39 out of the 46 daughters (84.8%) would be expected to receive full HPV vaccination after they take junior high school entrance examination or after 9-valent HPV vaccination is designated as a national routine-immunization.
This study revealed increasing number of our colleagues think HPV vaccination is necessary for prevention of cervical cancer. The Japanese government's decision to resume its recommendation of the HPV vaccine in November 2021 will lead to a change in the public's thinking and behavior toward the HPV vaccine.
日本政府于 2013 年暂停 HPV 疫苗推荐,导致接种率几乎降至零。我们在 2014 年至 2021 年期间对同事对 HPV 疫苗接种的态度进行了四次连续调查。在此,我们评估了 2021 年的调查结果,并将其与之前的调查进行了比较。
研究对象为 567 名曾在我们大学医院或附属医院接受培训的妇产科医生。我们使用的问卷形式与 2014 年、2017 年和 2019 年的问卷相似。
共有 340 名医生(60.0%)完成了调查。其中,93.2%(317/340)的受访者认为政府应重启 HPV 疫苗接种推荐,63.2%(215/340)认为青少年男性也应接种 HPV 疫苗。日本政府暂停 HPV 疫苗推荐后,青少年女儿接种 HPV 疫苗的比例为 43.5%(20/46),呈上升趋势。在接种 HPV 疫苗的 46 名女儿中,39 名(84.8%)有望在初中入学考试或 9 价 HPV 疫苗被指定为国家常规免疫后完成全程 HPV 疫苗接种。
本研究表明,越来越多的同事认为 HPV 疫苗接种对于预防宫颈癌是必要的。日本政府于 2021 年 11 月决定恢复 HPV 疫苗推荐,这将导致公众对 HPV 疫苗的看法和行为发生变化。